What Is Fair Pricing For Medicines? WHO-Netherlands Forum Aims To Find Out 01/03/2017 by William New, Intellectual Property Watch 4 Comments Public health stakeholders – and just about everyone else – may take notice of a meeting planned for May in the Netherlands, as it could offer the beginning of a new approach to pharmaceutical costs. High drug prices have become a ‘kitchen table’ issue in countries of all economic sizes recently, and the World Health Organization is teaming up with the Dutch government to address it in a new and practical way.
ICANN Is Moving Toward Copyright Enforcement, Academic Says 28/02/2017 by Dugie Standeford for Intellectual Property Watch 2 Comments The Internet Corporation for Assigned Names and Numbers (ICANN) is on an “ambivalent drift” into online content regulation through its contractual facilitation of a “trusted notifier” copyright enforcement program between the Motion Picture Association of America (MPAA) and the registry operators for two new generic top-level domains, University of Idaho College of Law Professor Annemarie Bridy says in a draft article for the Washington & Lee Law Review.
IP Scholars Warn About Stringent Copyright Rules In Asian RCEP Agreement 27/02/2017 by Intellectual Property Watch 1 Comment As negotiations take place this week in Japan for a free trade agreement covering the Asia-Pacific region, a group of intellectual property scholars is calling for the public interest to be clearly considered in the copyright rules of the future agreement.
US Business, Government Work To Bring Down ‘Dangerous’ UN Panel Report On Access To Medicines – And Change The Debate In Geneva 23/02/2017 by William New, Intellectual Property Watch 3 Comments Calling it flawed and narrow and seemingly threatened by its contents, the leading United States business group and US government IP specialists are working to limit the impact of a recent United Nations report that made recommendations for the decades-old problem of ensuring affordable medicines reach people when they are under patent in a way that does not threaten innovation. One step in countering the UN report? Change the discourse in Geneva and elsewhere.
Kenyan Regulator Cancels Leading Collective Management Licence To Streamline Music Royalties 22/02/2017 by Fredrick Nzwili for Intellectual Property Watch 1 Comment NAIROBI, Kenya — In a move meant to streamline the collection of music royalties in Kenya, the government regulator declined to renew a 2017 licence for a leading collective organisation over unmet standards.
ARIPO, OAPI To Harmonise Practices On Intellectual Property In Africa 21/02/2017 by Hillary Muheebwa for Intellectual Property Watch 1 Comment The African Regional Intellectual Property Organization (ARIPO) and its sister organisation, Organisation Africaine de la Propriété Intellectuelle [African Intellectual Property Organization] (OAPI) have signed a memorandum of understanding to harmonise the intellectual property systems of the two institutions.
BIO Investor Conference: New Technologies, Old Pricing Systems, And Insurance Payers In The US 20/02/2017 by Kim Treanor for Intellectual Property Watch 1 Comment NEW YORK — At a recent biotechnology investors event in the United States, the prospect of repeal or redesign of the Affordable Care Act, the president’s recent remarks on the prospect of Medicare negotiating prices directly with pharmaceutical corporations, and the public debate surrounding high priced medicines, meant few panels were immune from questions of affordability, access and payment.
Special Report: WHO Board Sets Review Of 10-Year Effort To Boost Medicines Access, Affordability 16/02/2017 by William New, Intellectual Property Watch 1 Comment Once considered a breakthrough in negotiations to address problems of making cutting-edge medical products and research available to poor countries, the decade-old World Health Organization Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPOA) is now undergoing review, with the WHO Executive Board calling for a report on the initiative and plans for its future next year.
Kenya Works With Communities On Genetic Resources And Traditional Knowledge Protection 15/02/2017 by Justus Wanzala for Intellectual Property Watch Leave a Comment NAIROBI, Kenya — Excessive degradation and over-exploitation of plant biodiversity in Kenya has led to depletion of some species and narrowed their genetic base. Apart from the conservation challenge, utilisation and sharing of benefits from plant genetic resources and traditional and associated knowledge among communities has also remained opaque despite constitutional guarantees.
The Problem With Rare Diseases: R&D Lacking, High Prices, Discrimination, IP Issues 13/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Over 6,000 rare diseases, those affecting very small populations, have been documented in the world. For those affected, treatments are mostly non-existent, and if they do exist, are not affordable. An event last week gathered a number of stakeholders, including rare disease organisations, the World Health Organization and the pharmaceutical industry to discuss the particular issue of rare diseases. The case of rare diseases is an exacerbated example of research, pricing, accessibility and affordability.